158 related articles for article (PubMed ID: 10092105)
21. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
22. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activation by airway smooth muscle is regulated by type I collagen.
Schuliga M; Harris T; Stewart AG
Am J Respir Cell Mol Biol; 2011 Jun; 44(6):831-9. PubMed ID: 20693403
[TBL] [Abstract][Full Text] [Related]
24. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
Reinartz J; Link J; Todd RF; Kramer MD
Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
[TBL] [Abstract][Full Text] [Related]
25. Potential role for insulin-like growth factor II and vitronectin in the endothelial-mesenchymal transition process.
Arciniegas E; Neves YC; Carrillo LM
Differentiation; 2006 Jul; 74(6):277-92. PubMed ID: 16831197
[TBL] [Abstract][Full Text] [Related]
26. Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells.
de Bleser PJ; Jannes P; van Buul-Offers SC; Hoogerbrugge CM; van Schravendijk CF; Niki T; Rogiers V; van den Brande JL; Wisse E; Geerts A
Hepatology; 1995 May; 21(5):1429-37. PubMed ID: 7737649
[TBL] [Abstract][Full Text] [Related]
27. Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction.
Nykjaer A; Christensen EI; Vorum H; Hager H; Petersen CM; Røigaard H; Min HY; Vilhardt F; Møller LB; Kornfeld S; Gliemann J
J Cell Biol; 1998 May; 141(3):815-28. PubMed ID: 9566979
[TBL] [Abstract][Full Text] [Related]
28. Structure of uPAR, plasminogen, and sugar-binding sites of the 300 kDa mannose 6-phosphate receptor.
Olson LJ; Yammani RD; Dahms NM; Kim JJ
EMBO J; 2004 May; 23(10):2019-28. PubMed ID: 15085180
[TBL] [Abstract][Full Text] [Related]
29. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
[TBL] [Abstract][Full Text] [Related]
30. Plasmin is not protective in experimental renal interstitial fibrosis.
Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR
Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
[TBL] [Abstract][Full Text] [Related]
32. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes.
Pedrozo HA; Schwartz Z; Robinson M; Gomes R; Dean DD; Bonewald LF; Boyan BD
Endocrinology; 1999 Dec; 140(12):5806-16. PubMed ID: 10579347
[TBL] [Abstract][Full Text] [Related]
33. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis.
Brauer PR; Yee JA
Dev Biol; 1993 Jan; 155(1):281-5. PubMed ID: 8416842
[TBL] [Abstract][Full Text] [Related]
34. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.
Dennis PA; Rifkin DB
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):580-4. PubMed ID: 1846448
[TBL] [Abstract][Full Text] [Related]
35. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
Albo D; Rothman VL; Roberts DD; Tuszynski GP
Br J Cancer; 2000 Aug; 83(3):298-306. PubMed ID: 10917542
[TBL] [Abstract][Full Text] [Related]
36. Latent TGF-beta1 activation by platelets.
Blakytny R; Ludlow A; Martin GE; Ireland G; Lund LR; Ferguson MW; Brunner G
J Cell Physiol; 2004 Apr; 199(1):67-76. PubMed ID: 14978736
[TBL] [Abstract][Full Text] [Related]
37. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
38. Tissue plasminogen activator is a ligand of cation-independent mannose 6-phosphate receptor and consists of glycoforms that contain mannose 6-phosphate.
Miller JJ; Bohnsack RN; Olson LJ; Ishihara M; Aoki K; Tiemeyer M; Dahms NM
Sci Rep; 2021 Apr; 11(1):8213. PubMed ID: 33859256
[TBL] [Abstract][Full Text] [Related]
39. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
[TBL] [Abstract][Full Text] [Related]
40. Cardiomyocytes bind and activate native human prorenin : role of soluble mannose 6-phosphate receptors.
Saris JJ; Derkx FH; Lamers JM; Saxena PR; Schalekamp MA; Danser AH
Hypertension; 2001 Feb; 37(2 Pt 2):710-5. PubMed ID: 11230361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
